Cover Image

Emerging biomarkers in the diagnosis of prostate cancer

Xavier Filella, Esther Fernández-Galan, Rosa Fernández Bonifacio, Laura Foj Department of Biochemistry and Molecular Genetics (CDB), Hospital Clínic, IDIBAPS, Barcelona, Catalonia, Spain Abstract: Prostate cancer (PCa) is the second most common cancer in men worldwide. A large proportion of PCa are...

Full description

Saved in:

Bibliographic Details
Main Authors:	Filella X (Author), Fernández-Galan E (Author), Fernández Bonifacio R (Author), Foj L (Author)
Format:	Book
Published:	Dove Medical Press, 2018-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Review of commercially available biomarkers in the diagnosis of prostate cancer
by: Magdalena Ostrowska, et al.
Published: (2022)

Can Prostate Specific Antigen Be Used as New Biomarker for Early Diagnosis of Breast Cancer?
by: Seyed Mostafa Shiryazdi, et al.
Published: (2015)

Diagnostic, Prognostic and Predictive Biomarkers in Prostate Cancer
by: Carsten Stephan (Ed.)
Published: (2017)

miRNAs as Therapeutic Tools and Biomarkers for Prostate Cancer
by: Noemi Arrighetti, et al.
Published: (2021)

SNW1 is a prognostic biomarker in prostate cancer
by: Doris Höflmayer, et al.
Published: (2019)

The prostate tissue‐based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy
by: Christopher M Heaphy, et al.
Published: (2022)

Detection and Prognosis of Prostate Cancer Using Blood-Based Biomarkers
by: Wei Jin, et al.
Published: (2020)

CRISP3 glycoprotein: a good biomarker for prostate cancer?
by: Aparecida de Lourdes Carvalho, et al.
Published: (2021)

Plasma 5-miRNA as Biomarkers for Identifying Prostate Cancer Patients
by: Mojtaba SAFFARI, et al.
Published: (2019)

Integrated analysis identifies GABRB3 as a biomarker in prostate cancer
by: Jun-Yan Chen, et al.
Published: (2024)

Future theranostic strategies: emerging ovarian cancer biomarkers to bridge the gap between diagnosis and treatment
by: Weranga Rajapaksha, et al.
Published: (2024)

Prostate-specific antigen velocity in diagnosis and prognosis of prostate cancer - a systematic review
by: Arslaan Javaeed, et al.
Published: (2020)

Microbiome and Prostate Cancer: Emerging Diagnostic and Therapeutic Opportunities
by: Sung Jin Kim, et al.
Published: (2024)

Exploring CD39 and CD73 Expression as Potential Biomarkers in Prostate Cancer
by: Carla Fernanda Furtado Gardani, et al.
Published: (2023)

Biomarkers and Fever in Children with Cancer: Kinetics and Levels According to Final Diagnosis
by: Ana de Lucio Delgado, et al.
Published: (2021)

A Synchronous Diagnosis of Metastatic Male Breast Cancer and Prostate Cancer
by: Leila Moosavi MD, et al.
Published: (2019)

Biomarkers of prostate bladder and testicular cancers: current use in anatomic pathology and future directions
by: Mariana Andozia Morini, et al.
Published: (2024)

Decision regret after prostate biopsy for prostate cancer diagnosis: a Korean multicenter cohort study
by: Hwanik Kim, et al.
Published: (2024)

Developments in radionanotheranostic strategies for precision diagnosis and treatment of prostate cancer
by: Jubilee Andrew, et al.
Published: (2024)

Emerging biomarkers for the diagnosis of severe neonatal infections applicable to low-resource settings
by: Thor A. Wagner, et al.
Published: (2011)

Prostate-specific Antigen as a Predictor for the Diagnosis of Prostate Adenocarcinoma
by: Wilfredo Valiente Morejón, et al.
Published: (2015)

Prostate-specific Antigen as a Predictor for the Diagnosis of Prostate Adenocarcinoma
by: Wilfredo Valiente Morejón, et al.
Published: (2015)

Apalutamide: Emerging Therapy for Non-Metastatic Castration-Resistant Prostate Cancer
by: Nora A. Alkhudair
Published: (2019)

Emerging Trends of Nanomedicines in the Management of Prostate Cancer: Perspectives and Potential Applications
by: Rohitas Deshmukh, et al.
Published: (2024)

Biomarker expression patterns that correlate with high grade features in treatment naive, organ-confined prostate cancer
by: McDonnell Timothy J, et al.
Published: (2008)

Role of Biomarkers in Screening and Diagnosis of Ovarian Cancer
by: Yenrudee Poomtavorn
Published: (2016)

THE VALUE OF SALIVARY BIOMARKERS IN ORAL CANCER DIAGNOSIS
by: Hurjui Loredana Liliana, et al.
Published: (2020)

A Mini-Review of Nanotechnology and Prostate Cancer: Approaches in Early Diagnosis
by: Marie Saghaeian Jazi
Published: (2020)

Perceptions towards diagnosis of prostate cancer in Tharaka Nithi County, Kenya
by: Timothy Kinoti Kirungia, et al.
Published: (2021)

Prostatic calculi cause osteoblastic immunophenotype of prostate cancer
by: A. M. Piddubnyi, et al.
Published: (2019)

General practitioners' reflections on using PSA for diagnosis of prostate cancer. A qualitative study
by: Olav Thorsen, et al.
Published: (2022)

Emerging Biomarkers for Prediction and Early Diagnosis of Necrotizing Enterocolitis in the Era of Metabolomics and Proteomics
by: Eleni Agakidou, et al.
Published: (2020)

Optimizing Local Therapy for High-Risk Prostate Cancer: Evidence and Emerging Options
Published: (2020)

Volume matters and intensification is needed: emerging trends in the management of advanced prostate cancer
by: Iris Y Sheng, et al.
Published: (2021)

Platelet protein biomarker panel for ovarian cancer diagnosis
by: Marta Lomnytska, et al.
Published: (2018)

Paraneoplastic antigens as biomarkers for early diagnosis of ovarian cancer
by: Madhumita Chatterjee, et al.
Published: (2017)

The latest reports on biomarkers used in the diagnosis of ovarian cancer
by: Aleksandra Chałupnik, et al.
Published: (2022)

Prostate Cancer
Published: (2018)

Prostate Cancer
Published: (2021)

Prostate Cancer
Published: (2023)